Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer.

Background: Basal-like breast cancer (BLBC) is a poorly characterised, heterogeneous disease. Patients are diagnosed with aggressive, high-grade tumours and often relapse with chemotherapy resistance. Detailed understanding of the molecular underpinnings of this disease is essential to the developme...

Descripción completa

Detalles Bibliográficos

Publicado en:	Breast Cancer Research Vol. 22; no. 1; pp. 1 - 19
Autores principales:	Baker, Laura A., Holliday, Holly, Roden, Daniel, Krisp, Christoph, Wu, Sunny Z., Junankar, Simon, Serandour, Aurelien A., Mohammed, Hisham, Nair, Radhika, Sankaranarayanan, Geetha, Law, Andrew M. K., McFarland, Andrea, Simpson, Peter T., Lakhani, Sunil, Dodson, Eoin, Selinger, Christina, Anderson, Lyndal, Samimi, Goli, Hacker, Neville F., Lim, Elgene
Formato:	research Journal Article
Publicado:	BioMed Central 6/11/2020
Acceso en línea:	Ver este registro en EBSCOhost